Cargando…
Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial
AIMS: SAR247799 is a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 (S1P(1)) agonist designed to activate endothelial S1P(1) and provide endothelial‐protective properties, while limiting S1P(1) desensitization and consequent lymphocyte‐count reduction associated with higher doses. The aim was t...
Autores principales: | Bergougnan, Luc, Andersen, Grit, Plum‐Mörschel, Leona, Evaristi, Maria Francesca, Poirier, Bruno, Tardat, Agnes, Ermer, Marcel, Herbrand, Theresa, Arrubla, Jorge, Coester, Hans Veit, Sansone, Roberto, Heiss, Christian, Vitse, Olivier, Hurbin, Fabrice, Boiron, Rania, Benain, Xavier, Radzik, David, Janiak, Philip, Muslin, Anthony J., Hovsepian, Lionel, Kirkesseli, Stephane, Deutsch, Paul, Parkar, Ashfaq A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247405/ https://www.ncbi.nlm.nih.gov/pubmed/33125753 http://dx.doi.org/10.1111/bcp.14632 |
Ejemplares similares
-
First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist for endothelial protection
por: Bergougnan, Luc, et al.
Publicado: (2020) -
A G-protein-biased S1P(1) agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome
por: Evaristi, Maria Francesca, et al.
Publicado: (2022) -
Injecting without pressing a button: An exploratory study of a shield‐triggered injection mechanism
por: Zijlstra, Eric, et al.
Publicado: (2018) -
Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial
por: Linnebjerg, Helle, et al.
Publicado: (2020) -
Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data
por: Andersen, Grit, et al.
Publicado: (2020)